WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 2625

Legislative bill overview

SB 2625 is a Texas bill currently in early legislative stages that addresses the provision of abortion-inducing drugs (medication abortion). The bill was introduced by State Senators Angela Paxton and Donna Campbell and was referred to the State Affairs Committee in April 2025. Specific provisions are not yet publicly detailed given its first-reading status.

Why is this important

Texas has some of the nation's most restrictive abortion laws, including a near-total ban with limited exceptions. Any legislation affecting abortion-inducing drugs directly impacts reproductive healthcare access in the state and potentially sets precedent for other states. Given Texas's large population and influence, this bill could affect healthcare policy discussions nationally.

Potential points of contention

  • Restrictions vs. access: The bill likely either further restricts medication abortion access or, conversely, protects it—each position generates intense debate between abortion-rights and abortion-restriction advocates
  • Federal-state jurisdiction: Medication abortion involves FDA-approved drugs, creating tension between federal drug regulations and state restrictions
  • Healthcare provider concerns: Medical professionals may object to restrictions on prescribing FDA-approved medications or to requirements that could complicate clinical practice

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.